FI971026A - Kinoksaliinidioni-NMDA-reseptoriantagonisteja - Google Patents
Kinoksaliinidioni-NMDA-reseptoriantagonisteja Download PDFInfo
- Publication number
- FI971026A FI971026A FI971026A FI971026A FI971026A FI 971026 A FI971026 A FI 971026A FI 971026 A FI971026 A FI 971026A FI 971026 A FI971026 A FI 971026A FI 971026 A FI971026 A FI 971026A
- Authority
- FI
- Finland
- Prior art keywords
- pct
- alkyl
- group
- date mar
- ch2ch3
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title abstract 2
- SEPKUNXLGWMPHL-UHFFFAOYSA-N quinoxaline-2,3-dione Chemical compound C1=CC=CC2=NC(=O)C(=O)N=C21 SEPKUNXLGWMPHL-UHFFFAOYSA-N 0.000 title 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
- 206010019196 Head injury Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 125000002785 azepinyl group Chemical group 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9418443 | 1994-09-13 | ||
| GB9418443A GB9418443D0 (en) | 1994-09-13 | 1994-09-13 | Therapeutic agents |
| PCT/EP1995/003483 WO1996008485A1 (en) | 1994-09-13 | 1995-09-01 | Quinoxalinedione nmda receptor antagonists |
| EP9503483 | 1995-09-01 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI971026A0 FI971026A0 (fi) | 1997-03-12 |
| FI971026A true FI971026A (fi) | 1997-03-12 |
| FI113471B FI113471B (fi) | 2004-04-30 |
Family
ID=10761258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI971026A FI113471B (fi) | 1994-09-13 | 1997-03-12 | Kinoksaliinidioni-NMDA-reseptoriantagonisteja |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5783572A (fi) |
| EP (1) | EP0781279B1 (fi) |
| JP (1) | JP2898097B2 (fi) |
| AT (1) | ATE202099T1 (fi) |
| CA (1) | CA2199845C (fi) |
| DE (1) | DE69521323T2 (fi) |
| DK (1) | DK0781279T3 (fi) |
| ES (1) | ES2158126T3 (fi) |
| FI (1) | FI113471B (fi) |
| GB (1) | GB9418443D0 (fi) |
| GR (1) | GR3036270T3 (fi) |
| MX (1) | MX9701894A (fi) |
| PT (1) | PT781279E (fi) |
| WO (1) | WO1996008485A1 (fi) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5874426A (en) * | 1995-06-07 | 1999-02-23 | Warner-Lambert Company | Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6110911A (en) * | 1995-06-07 | 2000-08-29 | Warner-Lambert Company | Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| MY132385A (en) * | 1995-08-31 | 2007-10-31 | Novartis Ag | 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives |
| GB9605027D0 (en) | 1996-03-09 | 1996-05-08 | Pfizer Ltd | Quinoxalinediones |
| AU5367598A (en) * | 1996-11-25 | 1998-06-22 | Warner-Lambert Company | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6172065B1 (en) | 1997-03-04 | 2001-01-09 | Warner-Lambert Company | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6340758B1 (en) * | 1997-05-16 | 2002-01-22 | Warner-Lambert Company | Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
| TW403740B (en) | 1997-06-10 | 2000-09-01 | Novartis Ag | Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide |
| DE19936521A1 (de) * | 1999-08-06 | 2001-02-15 | Gruenenthal Gmbh | Substituierte Pyrrolidin-2,3,4-trion-3-oxim-Derivate |
| AU2002250256B2 (en) * | 2001-03-08 | 2008-04-03 | Emory University | pH-dependent NMDA receptor antagonists |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| CN101087618A (zh) * | 2004-12-23 | 2007-12-12 | 航行药物公司 | 醋酸亮丙瑞林和乙酰胆碱酯酶抑制剂或nmda受体抑制剂在阿尔茨海默氏病治疗中的应用 |
| WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| EP2091948B1 (en) | 2006-11-30 | 2012-04-18 | Probiodrug AG | Novel inhibitors of glutaminyl cyclase |
| MX2009009234A (es) | 2007-03-01 | 2009-12-01 | Probiodrug Ag | Uso nuevo de inhibidores de ciclasa de glutaminilo. |
| EP2865670B1 (en) | 2007-04-18 | 2017-01-11 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
| CN103497114A (zh) * | 2007-06-29 | 2014-01-08 | 埃莫里大学 | 用于神经保护的nmda受体拮抗剂 |
| ES2548913T3 (es) | 2009-09-11 | 2015-10-21 | Probiodrug Ag | Derivados heterocíclicos como inhibidores de glutaminil ciclasa |
| ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
| EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
| CN103328452A (zh) * | 2010-12-13 | 2013-09-25 | 威尔金制药有限公司 | 金属酶抑制剂化合物 |
| US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
| DE102015011861B4 (de) | 2015-09-10 | 2018-03-01 | Rudolf Schindler | Neue cyclische Carboxamide als NMDA NR2B Rezeptor Inhibitoren |
| DK3461819T3 (da) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | Inhibitorer af glutaminylcyklase |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ221729A (en) * | 1986-09-15 | 1989-07-27 | Janssen Pharmaceutica Nv | Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions |
| GB8827822D0 (en) * | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
| DK715888D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
| DE4217952A1 (de) * | 1992-05-30 | 1993-12-02 | Basf Ag | Chinoxalin-2,3(1H,4H)-dione |
| EP0647137B1 (en) * | 1992-06-22 | 2008-08-13 | The Regents Of The University Of California | Glycine receptor antagonists and the use thereof |
-
1994
- 1994-09-13 GB GB9418443A patent/GB9418443D0/en active Pending
-
1995
- 1995-09-01 ES ES95931989T patent/ES2158126T3/es not_active Expired - Lifetime
- 1995-09-01 US US08/793,896 patent/US5783572A/en not_active Expired - Fee Related
- 1995-09-01 DK DK95931989T patent/DK0781279T3/da active
- 1995-09-01 CA CA002199845A patent/CA2199845C/en not_active Expired - Fee Related
- 1995-09-01 PT PT95931989T patent/PT781279E/pt unknown
- 1995-09-01 JP JP8509872A patent/JP2898097B2/ja not_active Expired - Fee Related
- 1995-09-01 AT AT95931989T patent/ATE202099T1/de not_active IP Right Cessation
- 1995-09-01 DE DE69521323T patent/DE69521323T2/de not_active Expired - Fee Related
- 1995-09-01 MX MX9701894A patent/MX9701894A/es not_active IP Right Cessation
- 1995-09-01 EP EP95931989A patent/EP0781279B1/en not_active Expired - Lifetime
- 1995-09-01 WO PCT/EP1995/003483 patent/WO1996008485A1/en active IP Right Grant
-
1997
- 1997-03-12 FI FI971026A patent/FI113471B/fi active
-
2001
- 2001-07-24 GR GR20010401119T patent/GR3036270T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT781279E (pt) | 2001-09-28 |
| DE69521323T2 (de) | 2001-09-20 |
| FI971026A0 (fi) | 1997-03-12 |
| WO1996008485A1 (en) | 1996-03-21 |
| EP0781279A1 (en) | 1997-07-02 |
| CA2199845A1 (en) | 1996-03-21 |
| US5783572A (en) | 1998-07-21 |
| GB9418443D0 (en) | 1994-11-02 |
| EP0781279B1 (en) | 2001-06-13 |
| DK0781279T3 (da) | 2001-09-03 |
| FI113471B (fi) | 2004-04-30 |
| GR3036270T3 (en) | 2001-10-31 |
| MX9701894A (es) | 1997-06-28 |
| DE69521323D1 (de) | 2001-07-19 |
| ES2158126T3 (es) | 2001-09-01 |
| JPH09511523A (ja) | 1997-11-18 |
| ATE202099T1 (de) | 2001-06-15 |
| JP2898097B2 (ja) | 1999-05-31 |
| CA2199845C (en) | 2000-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI971026A (fi) | Kinoksaliinidioni-NMDA-reseptoriantagonisteja | |
| FI962753A (fi) | Menetelmä lääkeaineena käytt¦kelpoisen piperidyyli- tai pyrrolidiinijohdannaisen tai sen farmaseuttisen suolan valmistamiseksi | |
| IL103657A0 (en) | Acyclic ethylenediamine derivatives | |
| DE69409525T2 (de) | Acetamidderivate und ihre verwendung als modifizierungsmittel des verhaltens der verdauung | |
| NZ508910A (en) | Di-substituted piperazine or piperidine derivatives useful as muscarinic antagonists | |
| DE69225500T2 (de) | Chinazolinone als mittel gegen angina | |
| PT100620A (pt) | Derivados de tetra-hidrocarbazol, seu uso e preparacao e composicoes farmaceuticas que os contem | |
| DE69402981D1 (de) | 3,5-dioxo-(2h,4h)-1,2,4-triazine als 5ht1a ligande | |
| ATE297381T1 (de) | Ether-muskarinantagonisten | |
| DE69216293D1 (de) | 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung | |
| NZ331060A (en) | Quinoxalinediones, preparation and pharmaceutical compositions thereof | |
| NZ331613A (en) | Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
| DK0510003T3 (da) | Piperidin-og pyrrolidinderivater | |
| YU140391A (sh) | 6-supstituisani-heksahidrobenz (cd)-indoli | |
| ATE144509T1 (de) | Imidazolylmethyl-pyridine | |
| ATE214056T1 (de) | Benzodiazepinderivate | |
| DK0461012T3 (da) | Derivater af ((1-arylpyrrolidin-2-yl)methyl)piperazin, fremstillingen heraf og deres terapeutiske anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: PFEIZER IRELAND PHARMACEUTICALS Free format text: PFEIZER IRELAND PHARMACEUTICALS |